T cells specific for a single viral epitope, but using different T cell receptors, should have flexibility in their epitope recognition to protect the infected host against the emergence of viral escape mutants. Therefore, polyclonality of the hepatitis B virus (HBV)-specific cytotoxic T lymphocyte response has been hypothesized to be a major determinant in the control of infection. We analyzed the Vbeta chain composition of the core 18-27-specific CD8 cells in acute and persistently HBV-infected patients using HLA-A2 tetrameric complexes and a panel of Vbeta antibodies. Different T cell receptors were utilized by core 18-27-specific CD8 cells both in patients with acute and chronic infection. The functional ability of these epitope-specific T cells to respond to potential viral mutations was then tested. The polyclonal HBV-specific CD8 response present in patients with acute hepatitis displayed a limited efficiency to recognize mutations introduced within the epitope. The ability of core 18-27-specific CD8 to tolerate epitope mutations was found only during persistent HBV infection. The data suggest that although a clonally heterogeneous CD8 response can be largely inhibited by the occurrence of single epitope mutations in primary HBV infection, preferential selection of T cells able to counteract the emergence of viral mutations can occur during persistent infection.

译文

对单个病毒表位特异的T细胞,但使用不同的T细胞受体,应在其表位识别方面具有灵活性,以保护受感染的宿主免受病毒逃逸突变体的出现。因此,乙型肝炎病毒 (HBV) 特异性细胞毒性T淋巴细胞反应的多克隆性被认为是控制感染的主要决定因素。我们使用HLA-A2四聚体复合物和一组Vbeta抗体分析了急性和持续HBV感染患者中核心18-27特异性CD8细胞的Vbeta链组成。在急性和慢性感染患者中,核心18-27特异性CD8细胞都利用了不同的T细胞受体。然后测试了这些表位特异性T细胞对潜在病毒突变的响应能力。急性肝炎患者中存在的多克隆HBV特异性CD8反应显示出识别表位内引入的突变的有限效率。仅在持续性HBV感染期间发现核心18-27特异性CD8耐受表位突变的能力。数据表明,虽然克隆异质性CD8反应可以在很大程度上抑制原发性HBV感染中发生单表位突变,但能够抵消病毒突变出现的T细胞的优先选择可以在持续感染期间发生。

+1
+2
100研值 100研值 ¥99课程
检索文献一次
下载文献一次

去下载>

成功解锁2个技能,为你点赞

《SCI写作十大必备语法》
解决你的SCI语法难题!

技能熟练度+1

视频课《玩转文献检索》
让你成为检索达人!

恭喜完成新手挑战

手机微信扫一扫,添加好友领取

免费领《Endnote文献管理工具+教程》

微信扫码, 免费领取

手机登录

获取验证码
登录